Report Objectives:#Â To define, describe, and forecast the Fertility Testing Technique Market based on product, application, mode of purchase, and end user.#Â To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges).#Â To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall fertility test market.#Â To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders.#Â To estimate the size & growth potential of the market segments and subsegments with respect to five key regionsâNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africaâand key countries.#Â To profile the key players in the market and comprehensively analyze their global revenue shares and core competencies.#Â To track and analyze competitive developments, such as product launches and approvals, partnerships, agreements, collaborations, and acquisitions in the Fertility Test Market.Download PDF Brochure@Â https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139945432Revenue Growth Expectations:The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5 %Â the forecast period.Growth Boosting Factors:Growth in Fertility Testing Technique Market is primarily driven by by the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed as well as developing countries.Restraint: Lesser precision of ovulation prediction kitsOvulation prediction kits measure the luteinizing hormone (LH) surge that precedes about 24â36 hours prior to ovulation.
In conditions such as luteinized unruptured follicle syndrome (in which a womanâs egg fails to emerge from its follicle after the LH surge occurs), ovulation predictors fail to give accurate results.
Also, urinary LH measurement is only predictive of the onset of ovulation and cannot determine the date of ovulation or anovulation, thereby only indicating a very small period (of only about two days) of the fertile window.Ovulation monitors can only test LH and do not identify other important ovulation signs, such as whether the cervical mucus is conductive for fertilization.
Also, these monitors do not work when certain fertility drugs, such as Pergonal or the hormone hCG (Human Chorionic Gonadotropin), are present in the urine.
The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for the confidentiality of test results.North America dominated the global fertilty test market in 2020North America, comprising the US and Canada, accounted for the largest share of the Fertility Testing Technique Market in 2020.
The large share of this region can primarily be attributed to factors such as high prevalence of infertility, increasing awareness about fertility testing among women, the rising age of first-time pregnancies in women, and the easy availability of ovulation and fertility monitors through e-commerce websites.Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=139945432Asia Pacific market is expected to grow at the highest CAGR during the forecast period.Growth in the Asia Pacific market is majorly due to the growing number of women suffering from lifestyle disorders, increasing funding/investments toward the development of fertility and ovulation monitors, and the growing focus of both international and domestic players on the Asia Pacific fertility test market.Key Market PlayersSwiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany), AdvaCare Pharma (US), AVA (Switzerland), Babystart (UK), Valley Electronics (Germany), Sensiia (UK), and Mira Care (US), among others are some of the major players operating in the global fertility test market.About MarketsandMarketsâ˘MarketsandMarkets⢠provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companiesâ revenues.